世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000038080

血液グループ化試薬の世界市場(2024-2028)

TechNavio

Global Blood-Grouping Reagents Market 2024-2028

発刊日 2024/03/05

言語英語

体裁PDF/172ページ

ライセンス/価格172ページ

0000038080

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

血液グループ化試薬市場は2023年から2028年に5億2,068万米ドル、予測期間中のCAGRは8.13%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、慢性疾患の有病率の増加、献血の増加、病院や血液バンクの数の増加によって牽引されています。

調査範囲

  • 市場セグメント
    ➣ エンドユーザー別
      ◇ 病院と血液バンク
      ◇ 臨床検査室
      ◇ 学術研究機関
    ➣ 技術別
      ◇ PCRベースおよびマイクロアレイ技術
      ◇ アッセイベースの技術
      ◇ 超並列シーケンシング技術
      ◇ 血清学
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域(ROW)

本調査では、診断機器の進歩が今後数年間の血液グループ化試薬市場成長を牽引する主要因の1つであるとしています。また、血液型分類におけるマルチプレックスアッセイの採用拡大、自動化とハイスループットプラットフォームの統合は、市場の大きな需要につながります。

血液グループ化試薬市場に関するレポートは、次の分野をカバーしています。

  • 血液グループ化試薬市場の規模
  • 血液グループ化試薬市場の予測
  • 血液グループ化試薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ AliveDX
    ➣ Arena Bio Scien
    ➣ ARKRAY Inc.
    ➣ Atlas Medical GmbH
    ➣ BAG Health Care GmbH
    ➣ Bio Rad Laboratories Inc.
    ➣ Calibre Scientific Inc.
    ➣ Danaher Corp.
    ➣ DIAGAST SAS
    ➣ Grifols SA
    ➣ Merck KGaA
    ➣ Novacyt SA
    ➣ QuidelOrtho Corp.
    ➣ Rapid Labs Ltd.
    ➣ Thermo Fisher Scientific Inc.
    ➣ Torax Biosciences Ltd.
    ➣ Tulip Diagnostics Pvt. Ltd.
    ➣ Fortress Diagnostics
    ➣ Paragon Care Ltd.
    ➣ VitroScient

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Technique
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global blood-grouping reagents market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global blood-grouping reagents market 2018 - 2022 ($ million)
4.2 End-User Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-User Segment 2018 - 2022 ($ million)
4.3 Technique Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Technique Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Hospitals and blood banks - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospitals and blood banks - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Hospitals and blood banks - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Hospitals and blood banks - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospitals and blood banks - Year-over-year growth 2023-2028 (%)
6.4 Clinical laboratories - Market size and forecast 2023-2028
Exhibit 38: Chart on Clinical laboratories - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Clinical laboratories - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Clinical laboratories - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Clinical laboratories - Year-over-year growth 2023-2028 (%)
6.5 Academic and research institutes - Market size and forecast 2023-2028
Exhibit 42: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ million)
Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Technique
7.1 Market segments
Exhibit 48: Chart on Technique - Market share 2023-2028 (%)
Exhibit 49: Data Table on Technique - Market share 2023-2028 (%)
7.2 Comparison by Technique
Exhibit 50: Chart on Comparison by Technique
Exhibit 51: Data Table on Comparison by Technique
7.3 PCR-based and microarray techniques - Market size and forecast 2023-2028
Exhibit 52: Chart on PCR-based and microarray techniques - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on PCR-based and microarray techniques - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on PCR-based and microarray techniques - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on PCR-based and microarray techniques - Year-over-year growth 2023-2028 (%)
7.4 Assay-based techniques - Market size and forecast 2023-2028
Exhibit 56: Chart on Assay-based techniques - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Assay-based techniques - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Assay-based techniques - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Assay-based techniques - Year-over-year growth 2023-2028 (%)
7.5 Massively parallel sequencing techniques - Market size and forecast 2023-2028
Exhibit 60: Chart on Massively parallel sequencing techniques - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Massively parallel sequencing techniques - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Massively parallel sequencing techniques - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Massively parallel sequencing techniques - Year-over-year growth 2023-2028 (%)
7.6 Serology - Market size and forecast 2023-2028
Exhibit 64: Chart on Serology - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Data Table on Serology - Market size and forecast 2023-2028 ($ million)
Exhibit 66: Chart on Serology - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Serology - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Technique
Exhibit 68: Market opportunity by Technique ($ million)
Exhibit 69: Data Table on Market opportunity by Technique ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Canada - Market size and forecast 2023-2028
Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 107: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 108: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 109: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 AliveDX
Exhibit 119: AliveDX - Overview
Exhibit 120: AliveDX - Product / Service
Exhibit 121: AliveDX - Key offerings
12.4 Arena Bio Scien
Exhibit 122: Arena Bio Scien - Overview
Exhibit 123: Arena Bio Scien - Product / Service
Exhibit 124: Arena Bio Scien - Key offerings
12.5 ARKRAY Inc.
Exhibit 125: ARKRAY Inc. - Overview
Exhibit 126: ARKRAY Inc. - Product / Service
Exhibit 127: ARKRAY Inc. - Key offerings
12.6 Atlas Medical GmbH
Exhibit 128: Atlas Medical GmbH - Overview
Exhibit 129: Atlas Medical GmbH - Product / Service
Exhibit 130: Atlas Medical GmbH - Key offerings
12.7 Bio Rad Laboratories Inc.
Exhibit 131: Bio Rad Laboratories Inc. - Overview
Exhibit 132: Bio Rad Laboratories Inc. - Business segments
Exhibit 133: Bio Rad Laboratories Inc. - Key news
Exhibit 134: Bio Rad Laboratories Inc. - Key offerings
Exhibit 135: Bio Rad Laboratories Inc. - Segment focus
12.8 Calibre Scientific Inc.
Exhibit 136: Calibre Scientific Inc. - Overview
Exhibit 137: Calibre Scientific Inc. - Product / Service
Exhibit 138: Calibre Scientific Inc. - Key offerings
12.9 Danaher Corp.
Exhibit 139: Danaher Corp. - Overview
Exhibit 140: Danaher Corp. - Business segments
Exhibit 141: Danaher Corp. - Key news
Exhibit 142: Danaher Corp. - Key offerings
Exhibit 143: Danaher Corp. - Segment focus
12.10 DIAGAST SAS
Exhibit 144: DIAGAST SAS - Overview
Exhibit 145: DIAGAST SAS - Product / Service
Exhibit 146: DIAGAST SAS - Key offerings
12.11 Grifols SA
Exhibit 147: Grifols SA - Overview
Exhibit 148: Grifols SA - Business segments
Exhibit 149: Grifols SA - Key offerings
Exhibit 150: Grifols SA - Segment focus
12.12 Merck KGaA
Exhibit 151: Merck KGaA - Overview
Exhibit 152: Merck KGaA - Business segments
Exhibit 153: Merck KGaA - Key news
Exhibit 154: Merck KGaA - Key offerings
Exhibit 155: Merck KGaA - Segment focus
12.13 Novacyt SA
Exhibit 156: Novacyt SA - Overview
Exhibit 157: Novacyt SA - Business segments
Exhibit 158: Novacyt SA - Key offerings
Exhibit 159: Novacyt SA - Segment focus
12.14 Paragon Care Ltd.
Exhibit 160: Paragon Care Ltd. - Overview
Exhibit 161: Paragon Care Ltd. - Business segments
Exhibit 162: Paragon Care Ltd. - Key offerings
Exhibit 163: Paragon Care Ltd. - Segment focus
12.15 QuidelOrtho Corp.
Exhibit 164: QuidelOrtho Corp. - Overview
Exhibit 165: QuidelOrtho Corp. - Product / Service
Exhibit 166: QuidelOrtho Corp. - Key offerings
12.16 Thermo Fisher Scientific Inc.
Exhibit 167: Thermo Fisher Scientific Inc. - Overview
Exhibit 168: Thermo Fisher Scientific Inc. - Business segments
Exhibit 169: Thermo Fisher Scientific Inc. - Key news
Exhibit 170: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 171: Thermo Fisher Scientific Inc. - Segment focus
12.17 Tulip Diagnostics Pvt. Ltd.
Exhibit 172: Tulip Diagnostics Pvt. Ltd. - Overview
Exhibit 173: Tulip Diagnostics Pvt. Ltd. - Product / Service
Exhibit 174: Tulip Diagnostics Pvt. Ltd. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 175: Inclusions checklist
Exhibit 176: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 177: Currency conversion rates for US$
13.4 Research methodology
Exhibit 178: Research methodology
Exhibit 179: Validation techniques employed for market sizing
Exhibit 180: Information sources
13.5 List of abbreviations
Exhibit 181: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Technique
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global blood-grouping reagents market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - End-User Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Technique Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on End-user - Market share 2023-2028 (%)
Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospitals and blood banks - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Hospitals and blood banks - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Hospitals and blood banks - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Hospitals and blood banks - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Clinical laboratories - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Clinical laboratories - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Clinical laboratories - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Clinical laboratories - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by End-user ($ million)
Exhibits47: Data Table on Market opportunity by End-user ($ million)
Exhibits48: Chart on Technique - Market share 2023-2028 (%)
Exhibits49: Data Table on Technique - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Technique
Exhibits51: Data Table on Comparison by Technique
Exhibits52: Chart on PCR-based and microarray techniques - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on PCR-based and microarray techniques - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on PCR-based and microarray techniques - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on PCR-based and microarray techniques - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Assay-based techniques - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Assay-based techniques - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Assay-based techniques - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Assay-based techniques - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Massively parallel sequencing techniques - Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Massively parallel sequencing techniques - Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Massively parallel sequencing techniques - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Massively parallel sequencing techniques - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Serology - Market size and forecast 2023-2028 ($ million)
Exhibits65: Data Table on Serology - Market size and forecast 2023-2028 ($ million)
Exhibits66: Chart on Serology - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Serology - Year-over-year growth 2023-2028 (%)
Exhibits68: Market opportunity by Technique ($ million)
Exhibits69: Data Table on Market opportunity by Technique ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits108: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits109: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2023 and 2028
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: AliveDX - Overview
Exhibits120: AliveDX - Product / Service
Exhibits121: AliveDX - Key offerings
Exhibits122: Arena Bio Scien - Overview
Exhibits123: Arena Bio Scien - Product / Service
Exhibits124: Arena Bio Scien - Key offerings
Exhibits125: ARKRAY Inc. - Overview
Exhibits126: ARKRAY Inc. - Product / Service
Exhibits127: ARKRAY Inc. - Key offerings
Exhibits128: Atlas Medical GmbH - Overview
Exhibits129: Atlas Medical GmbH - Product / Service
Exhibits130: Atlas Medical GmbH - Key offerings
Exhibits131: Bio Rad Laboratories Inc. - Overview
Exhibits132: Bio Rad Laboratories Inc. - Business segments
Exhibits133: Bio Rad Laboratories Inc. - Key news
Exhibits134: Bio Rad Laboratories Inc. - Key offerings
Exhibits135: Bio Rad Laboratories Inc. - Segment focus
Exhibits136: Calibre Scientific Inc. - Overview
Exhibits137: Calibre Scientific Inc. - Product / Service
Exhibits138: Calibre Scientific Inc. - Key offerings
Exhibits139: Danaher Corp. - Overview
Exhibits140: Danaher Corp. - Business segments
Exhibits141: Danaher Corp. - Key news
Exhibits142: Danaher Corp. - Key offerings
Exhibits143: Danaher Corp. - Segment focus
Exhibits144: DIAGAST SAS - Overview
Exhibits145: DIAGAST SAS - Product / Service
Exhibits146: DIAGAST SAS - Key offerings
Exhibits147: Grifols SA - Overview
Exhibits148: Grifols SA - Business segments
Exhibits149: Grifols SA - Key offerings
Exhibits150: Grifols SA - Segment focus
Exhibits151: Merck KGaA - Overview
Exhibits152: Merck KGaA - Business segments
Exhibits153: Merck KGaA - Key news
Exhibits154: Merck KGaA - Key offerings
Exhibits155: Merck KGaA - Segment focus
Exhibits156: Novacyt SA - Overview
Exhibits157: Novacyt SA - Business segments
Exhibits158: Novacyt SA - Key offerings
Exhibits159: Novacyt SA - Segment focus
Exhibits160: Paragon Care Ltd. - Overview
Exhibits161: Paragon Care Ltd. - Business segments
Exhibits162: Paragon Care Ltd. - Key offerings
Exhibits163: Paragon Care Ltd. - Segment focus
Exhibits164: QuidelOrtho Corp. - Overview
Exhibits165: QuidelOrtho Corp. - Product / Service
Exhibits166: QuidelOrtho Corp. - Key offerings
Exhibits167: Thermo Fisher Scientific Inc. - Overview
Exhibits168: Thermo Fisher Scientific Inc. - Business segments
Exhibits169: Thermo Fisher Scientific Inc. - Key news
Exhibits170: Thermo Fisher Scientific Inc. - Key offerings
Exhibits171: Thermo Fisher Scientific Inc. - Segment focus
Exhibits172: Tulip Diagnostics Pvt. Ltd. - Overview
Exhibits173: Tulip Diagnostics Pvt. Ltd. - Product / Service
Exhibits174: Tulip Diagnostics Pvt. Ltd. - Key offerings
Exhibits175: Inclusions checklist
Exhibits176: Exclusions checklist
Exhibits177: Currency conversion rates for US$
Exhibits178: Research methodology
Exhibits179: Validation techniques employed for market sizing
Exhibits180: Information sources
Exhibits181: List of abbreviations

この商品のレポートナンバー

0000038080

TOP